Form
Approved
OMB No. 0935-XXXX
Exp. Date XX/XX/20XX
AHRQ Safety Program for MRSA Prevention
Clinical Outcomes Data for ICU/Non-ICU
Month, Year |
Count of MRSA bacteremia LabID events by month and community vs. hospital onset |
Designation as either community onset (Day 1 or 2 of hospital admission) or hospital onset (Day 3 or after of hospital admission) – selected from dropdown menu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This includes MRSA as well as well as other causative organisms.
Month, Year |
Count of HOB cases by each causative organism |
Organism – selected from dropdown menu (See List of Organisms, page 6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public
reporting burden for this collection of information is estimated to
average 30 minutes per response, the estimated time required to
complete the survey. An agency may not conduct or sponsor, and
a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number. Send
comments regarding this burden estimate or any other aspect of
this collection of information, including suggestions for reducing
this burden, AHRQ Reports Clearance Officer, Attention: PRA,
Paperwork Reduction Project (0935-0143), AHRQ, 5600 Fishers Lane, MS
0741A, Rockville, MD 20857
The
confidentiality of your responses is protected by Sections 944(c)
and 308(d) of the Public Health Service Act [42 U.S.C. 299c-3(c) and
42 U.S.C. 242m(d)]. Information that could identify you will not be
disclosed unless you have consented to that disclosure.
Month, Year |
Count of CLABSI cases by each causative organism |
Organism – selected from dropdown menu (See List of Organisms, page 6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Month, Year |
Total central line days |
|
|
|
|
|
|
Month, Year |
Total patient days |
|
|
|
|
|
|
Month, Year |
Count of clinical cultures growing MRSA on Day 3 or later of hospital admission by specimen type |
Specimen type – selected from dropdown menu (See List of Specimen Types, page 7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of patients with positive result on MRSA nasal surveillance testing during a designated 3-day time window |
Number of total surveillance tests performed during a designated 3-day time window |
_________________ |
_________________ |
Staphylococcus aureus |
Methicillin-resistant (MRSA) |
Methicillin-susceptible (MSSA) |
Coagulase-Negative Staphylococcus |
Candida |
Candida albicans |
Candida glabrata |
Candida parapsilosis |
Candida tropicalis |
Candida krusei |
Candida lusitaniae |
Candida sp.(unspeciated) |
Enterococcus |
Enterococcus faecalis |
Enterococcus faecium |
Enterococcus sp. |
Klebsiella |
Klebsiella pneumoniae |
Klebsiella oxytoca |
Escherichia coli |
Enterobacter |
Enterobacter cloacae |
Enterobacter aerogenes |
Enterobacter agglomerans |
Enterobacter sp. |
Pseudomonas |
Pseudomonas aeruginosa |
Pseudomonas sp. |
Streptococcus |
Streptococcus viridans grp |
Streptococcus, Group B |
Streptococcus pneumoniae |
Streptococcus, Group A |
Streptococcus, Group C |
Streptococcus anginosis grp |
Streptococcus, Group F |
Streptococcus, Group G |
Acinetobacter |
Acinetobacter baumannii |
Acinetobacter lwoffii |
Serratia |
Serratia marcescens |
Serratia sp. |
Bacteroides |
Bacteroides fragilis |
Bacteroides, other sp. |
Proteus mirabilis |
Stenotrophomonas maltophilia |
Clostridium |
Citrobacter |
Citrobacter freundii |
Citrobacter koseri |
Morganella morganii |
Achromobacter sp. |
Providencia stuartii |
Alcaligenes xylosoxidans |
Pantoea agglomerans |
Other |
List of Specimen Types
Blood culture |
Urine culture |
Sputum culture |
Wound culture |
Abscess fluid |
Peritoneal fluid |
Pleural fluid |
Cerebral spinal fluid |
Joint aspiration fluid |
Hardware or device (explanted) |
Tissue culture |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Samuel Kim |
File Modified | 0000-00-00 |
File Created | 2022-10-20 |